Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT)

NCT01614457 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Ivacaftor
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated

Collaborators

[object Object]